Validations: Intended Use, Data Readiness & Bias

Executive One-Pager: Intended Use & Data Readiness

Executive One-Pager: Intended Use & Data Readiness Executive One-Pager: Intended Use & Data Readiness Introduction to AI/ML Model Validation in GxP Analytics The utilization of artificial intelligence (AI) and machine learning (ML) technologies in Good Automated Manufacturing Practice (GxP) systems represents a growing trend within the pharmaceutical and clinical operations industries. As AI/ML models become more integrated into processes that…

Continue Reading Executive One-Pager: Intended Use & Data Readiness

Model Use Restrictions: Where Not to Use AI

Model Use Restrictions: Where Not to Use AI Model Use Restrictions: Where Not to Use AI The integration of Artificial Intelligence (AI) and Machine Learning (ML) models into pharmaceutical environments has accelerated innovation and enhanced efficiencies. However, their application is not without concerns. This tutorial guide will elucidate the intricacies of AI/ML model validation, particularly focusing on the intended use,…

Continue Reading Model Use Restrictions: Where Not to Use AI

Edge Cases & Rare Events: Handling Strategies

Edge Cases & Rare Events: Handling Strategies Edge Cases & Rare Events: Handling Strategies Introduction to AI/ML Model Validation in GxP Analytics Artificial Intelligence (AI) and Machine Learning (ML) have revolutionized various sectors, particularly in pharmaceutical and clinical operations. The application of these technologies necessitates rigorous validation processes to ensure compliance with Good Automated Manufacturing Practice (GxP) regulations. AI/ML model…

Continue Reading Edge Cases & Rare Events: Handling Strategies

Ground Truth Drift: Monitoring and Refresh

Ground Truth Drift: Monitoring and Refresh in AI/ML Model Validation In the evolving landscape of pharmaceutical development, the integration of artificial intelligence (AI) and machine learning (ML) into Good Practice (GxP) analytics has become imperative. As organizations adopt these advanced technologies, ensuring compliance with regulatory expectations such as 21 CFR Part 11, Annex 11, and GAMP 5 is crucial. This…

Continue Reading Ground Truth Drift: Monitoring and Refresh

Transfer Learning in GxP: Evidence Expectations

Transfer Learning in GxP: Evidence Expectations Transfer Learning in GxP: Evidence Expectations Introduction to Transfer Learning in GxP In the era of digital transformation, the pharmaceutical industry is increasingly harnessing the power of Artificial Intelligence (AI) and Machine Learning (ML) to enhance operational efficiencies and improve patient outcomes. However, with the introduction of these advanced technologies comes the need for…

Continue Reading Transfer Learning in GxP: Evidence Expectations

Domain Shift Across Sites: Parity and Exceptions

Domain Shift Across Sites: Parity and Exceptions The integration of artificial intelligence (AI) and machine learning (ML) within Good Practice (GxP) analytics is reshaping pharmaceutical validation processes. This guide seeks to provide a comprehensive step-by-step tutorial on the validation of AI/ML models, with a particular focus on domain shift across sites, ensuring compliance with regulatory expectations under the US FDA,…

Continue Reading Domain Shift Across Sites: Parity and Exceptions

Intended Use Storyboards for Inspections

Intended Use Storyboards for Inspections Intended Use Storyboards for Inspections Introduction to AI/ML Model Validation The utilization of Artificial Intelligence (AI) and Machine Learning (ML) in GxP (Good Practice) analytics has become a cornerstone of modern pharmaceutical development. As the complexity of these technologies increases, regulatory bodies such as the FDA, EMA, and MHRA have provided guidance to ensure compliance…

Continue Reading Intended Use Storyboards for Inspections

Case Library: Data Readiness Wins and Fails

Case Library: Data Readiness Wins and Fails In the realm of pharmaceutical development, the integration of AI and machine learning (ML) into Good Automated Manufacturing Practice (GxP) analytics has become increasingly vital. The validation of these models, specifically in terms of data readiness, intended use, and bias, is crucial for regulatory compliance. The purpose of this guide is to provide…

Continue Reading Case Library: Data Readiness Wins and Fails

Templates: Data Readiness & Bias Assessment

Templates: Data Readiness & Bias Assessment Templates: Data Readiness & Bias Assessment Introduction to AI/ML Model Validation in GxP In the evolving landscape of pharmaceutical and clinical operations, AI/ML model validation plays a pivotal role in ensuring compliance with Good Automated Manufacturing Practice (GxP) regulations. These regulations are critical under the scrutiny of the US FDA, EMA, MHRA, and PIC/S….

Continue Reading Templates: Data Readiness & Bias Assessment

Human-in-the-Loop Design for Intended Use

Human-in-the-Loop Design for Intended Use Human-in-the-Loop Design for Intended Use in AI/ML Model Validation As the pharmaceutical industry increasingly embraces artificial intelligence (AI) and machine learning (ML) technologies, the importance of rigorous validation practices tailored to meet real-world regulatory requirements has never been more pronounced. This comprehensive guide serves as a step-by-step tutorial on effectively implementing human-in-the-loop (HITL) design principles…

Continue Reading Human-in-the-Loop Design for Intended Use